AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 ArdelyxUrogen PharmaBeyondspringMerusOrganogenesis
SymbolNASDAQ:ARDXNASDAQ:URGNNASDAQ:BYSINASDAQ:MRUSNASDAQ:ORGO
Price Information
Current Price$7.33$24.00$16.47$14.14$4.61
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.61.61.31.42.1
Analysis Score3.53.33.53.33.5
Community Score2.73.12.62.52.5
Dividend Score0.00.00.00.00.0
Ownership Score1.01.00.01.04.0
Earnings & Valuation Score0.60.60.60.00.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$12.00$46.00$29.67$19.67$7.75
% Upside from Price Target63.71% upside91.67% upside80.13% upside39.09% upside68.11% upside
Trade Information
Market Cap$643.85 million$534.75 million$474.61 million$413.76 million$367.13 million
Beta1.891.731.110.81N/A
Average Volume791,290230,85348,880103,569121,864
Sales & Book Value
Annual Revenue$5.28 million$20,000.00N/A$31.13 million$260.98 million
Price / Sales123.4625,076.40N/A13.191.87
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$1.89 per share$7.20 per share$1.12 per share$3.95 per share$0.38 per share
Price / Book3.883.33N/A3.5812.13
Profitability
Net Income$-94,940,000.00$-105,150,000.00$-38,080,000.00$-55,150,000.00$-40,450,000.00
EPS($1.47)($5.12)($1.55)($2.33)($0.42)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-1,403.90%N/AN/A-225.21%-15.48%
Return on Equity (ROE)-77.23%-63.41%-431.19%-62.96%-124.66%
Return on Assets (ROA)-48.46%-58.23%-171.68%-27.54%-21.30%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.26%N/A0.11%N/A2.61%
Current Ratio9.76%8.58%4.06%6.34%2.03%
Quick Ratio9.76%8.58%4.06%6.34%1.55%
Ownership Information
Institutional Ownership Percentage86.08%64.18%6.60%62.02%3.63%
Insider Ownership Percentage15.31%12.00%N/AN/A70.40%
Miscellaneous
Employees8870N/A98700
Shares Outstanding88.93 million20.90 million27.89 million29.04 million106.11 million
Next Earnings Date8/14/2020 (Estimated)8/14/2020 (Estimated)7/8/2020 (Estimated)8/17/2020 (Estimated)8/14/2020 (Estimated)
OptionableOptionableOptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.